Adams Brian bought KYMR
March 2, 2026 · Form 4 insider transaction
Adams Brian bought 4,125 shares of Kymera Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,125
Price
$0.00
Total value
N/A
InsiderAdams Brian
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after56,625
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date.